October 2024 in “Revista Electronica de Veterinaria” Siddha medicine can effectively treat Alopecia areata, leading to significant hair regrowth.
October 2024 in “International journal of medicine and psychology.” Targeted immune modulation can help achieve stable remission in alopecia areata.
October 2024 in “Frontiers in Immunology” Pertussis toxin may contribute to hair loss in alopecia areata.
October 2024 in “Heliyon” Consider systemic lupus erythematosus in patients with unexplained intracranial hypertension.
October 2024 in “BMJ Case Reports” Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.
October 2024 in “The American Journal of Gastroenterology” Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.
September 2024 in “Annals of Medicine and Surgery” Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.
Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.
September 2024 in “Indian Journal of Skin Allergy” Technology, like stem cell therapy and teledermatology, is improving dermatology care.
September 2024 in “Cureus” Removing breast implants resolved the patient's symptoms.